<DOC>
	<DOCNO>NCT01619696</DOCNO>
	<brief_summary>The objective present project validate feasibility multimodal radiological pathway chemoradiotherapy , order validate potentially predictive factor chemoradiotherapy sensitivity rectal adenocarcinoma .</brief_summary>
	<brief_title>Prospective Pilot Study Multimodal Radiological Evaluation Feasibility During Chemoradiotherapy Rectal Adenocarcinomas</brief_title>
	<detailed_description>The objective present project validate feasibility multimodal radiological pathway chemoradiotherapy , order validate potentially predictive factor chemoradiotherapy sensitivity rectal adenocarcinoma . It base structured clinical radiological pathway patient , use diffusion MRI F misonidazole PET . Validation new tool already need clinical practice since future institutional trial base treatment individualisation , use preoperative predicting factor .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>locally advanced ( â‰¥T3 ) resectable rectal adenocarcinoma 2 10 cm anal verge . synchonous metastatis previous malignant tumour previous radiotherapy/ chemotherapy performance status WHO &gt; 2 contraindication 5 FU</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>chemotherapy</keyword>
	<keyword>rectal adenocarcinoma</keyword>
	<keyword>proctectomy</keyword>
	<keyword>Fmiso TEP</keyword>
	<keyword>MRI</keyword>
</DOC>